GlassScriptPhysician profile
Erasmo A Passaro
NPI 1972599439
$293,524.34
in general payments reported to CMS, 2019-2025
25 companies · $43K in 2025
The $43K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $12K · 2021: $5,890 · 2022: $49K · 2023: $64K · 2024: $78K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $79K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $74K · Travel and Lodging: $12K · Consulting Fee: $11K · Food and Beverage: $8,798 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $78,650.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $74,270.00 |
| Travel and Lodging | $12,210.67 |
| Consulting Fee | $11,220.00 |
| Food and Beverage | $8,797.84 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $116,087.46 | 2020-2025 | Xcopri |
| Ucb, INC. | $114,116.35 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Eisai INC. | $20,083.11 | 2019-2022 | |
| Neurelis, INC. | $19,127.35 | 2021-2025 | Valtoco |
| Sunovion Pharmaceuticals INC. | $11,366.53 | 2019-2022 | |
| Greenwich Biosciences, INC. | $8,528.41 | 2019-2021 | |
| Dixi Medical USA Corp | $980.82 | 2023 | |
| Abbvie INC. | $952.02 | 2022-2025 | |
| Neuropace, INC. | $621.23 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $594.11 | 2019-2025 | |
| Livanova USA, INC. | $271.51 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic USA, INC. | $178.27 | 2019 | |
| Sumitomo Pharma America, INC. | $150.07 | 2023-2024 | Aptiom |
| Aquestive Therapeutics, INC. | $133.63 | 2019 | |
| Zimmer Biomet Holdings, INC. | $56.67 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $53.59 | 2020 | |
| Monteris Medical Corporation | $31.98 | 2025 | Neuroblate |
| Amgen INC. | $31.54 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $29.43 | 2019 | |
| Supernus Pharmaceuticals, INC. | $27.26 | 2019 | |
| Biogen, INC. | $24.12 | 2019 | |
| Pfizer INC. | $21.17 | 2024 | |
| Akcea Therapeutics, INC. | $19.99 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.15 | 2019 | |
| Inspire Medical Systems, INC. | $18.57 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erasmo Passaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.